Gene Therapy In Mice Delays Onset Of Lou Gehrig's Disease

July 24, 1997

New York, NY July 24, 1997--Scientists studying mice genetically engineered to develop familial amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, have found that the human gene Bcl-2 may delay the onset of ALS. The study appears in the July 24 issue of Science.

ALS is the most common motor neuron disease in humans. Inherited ALS accounts for 15 percent of all cases of the disease, and patients have symptoms identical to the more common sporadic form. These include a progressive loss of motor neurons in the spinal cord that leads to muscle wasting, paralysis, and, ultimately, death. Currently, the only treatments for ALS are mechanical ventilation and, to a lesser extent, the drug riluzole.

Columbia University researchers at Columbia-Presbyterian Medical Center worked with two strains of transgenic mice: one carrying mutations that produced familial ALS and another carrying the human proto-oncogene Bcl-2, which is known to protect against apoptosis or cell death. The Bcl-2 mice carried 16 copies of the gene so that it would be "overexpressed" to maximize any protective effect against ALS.

Scientists bred the two strains of mice and discovered that offspring inheriting both ALS and Bcl-2 developed ALS significantly later in life--and in fact lived longer--than offspring that inherited ALS but not Bcl-2.

The mutant gene responsible for familial ALS is known as copper/zinc superoxide dismutase. This gene normally produces an enzyme that protects the body by ridding it of free radicals, unstable chemicals produced during metabolism that damage cell membranes, DNA, and other constituents of cells. People with a mutation of this gene presumably develop ALS because of free radical damage to their motor neurons. The study found that mice carrying the Bcl-2 gene had both more and healthier motor neurons than mice without Bcl-2.

"The study suggests that gene therapy--either with Bcl-2 or with another gene capable of preventing apoptosis--could help delay the onset of ALS," says Serge Przedborski, MD, PhD, principal investigator and assistant professor of neurology at Columbia University College of Physicians and Surgeons. The finding could also lead to the development of drugs that mimic proteins produced by Bcl-2 or other protective genes.

Columbia University researchers and colleagues from Hopitaut Universitaires de Geneve collaborated on the study, which was funded by the National Institute of Neurological Disorders and Stroke, a branch of the National Institutes of Health, and the Muscular Dystrophy Association.


Columbia University Medical Center

Related Motor Neurons Articles from Brightsurf:

Spinal injuries: the recovery of motor skills thanks to nanomaterials
Re-establishing motor skills and neuronal connectivity thanks to the implantation of carbon nanotubes in the injury site.

The smallest motor in the world
A research team from Empa and EPFL has developed a molecular motor which consists of only 16 atoms and rotates reliably in one direction.

Mechanism behind upper motor degeneration revealed
Scientists have pinpointed the electrophysiological mechanism behind upper motor neuron disease, unlocking the door to potential treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, such as Hereditary Spastic Paraplegia and Primary Lateral Sclerosis.

Synergy emergence in deep reinforcement motor learning
Human motor control has always been efficient at executing complex movements naturally, efficiently, and without much thought involved.

How your brain remembers motor sequences
Researchers at the National Institute of Information and Communications Technology (NICT), Japan, and Western University, Canada, have succeeded in visualizing how information is represented in a widespread area in the human cerebral cortex during a performance of skilled finger movement sequences.

Tiny motor can 'walk' to carry out tasks
MIT researchers have assembled microrobots from a small set of standardized components, as a step toward self-replicating systems.

Statins could protect against motor neurone disease
High cholesterol has been found to be a possible risk factor for the development of motor neurone disease (MND), according to a large study of genetic data led in the UK by Queen Mary University of London, in collaboration with the National Institutes of Health in the USA.

Scientists accidentally reprogram mature mouse GABA neurons into dopaminergic-like neurons
Attempting to make dopamine-producing neurons out of glial cells in mouse brains, a group of researchers instead converted mature inhibitory neurons into dopaminergic cells.

Motor learning for precise motor execution
Scientists at Tokyo Metropolitan Institute of Medical Science, RIKEN, National Center of Neurology and Psychiatry, Nozomi Hospital and Tokyo Medical and Dental University have identified acquisition of two types of internal models for motor control, which are likely to be stored in the cerebellum.

Molecular motor: Four states of rotation
With the help of ultrafast spectroscopy and quantum mechanical calculations, Ludwig-Maximilians-Universitaet (LMU) in Munich researchers have characterized the complete rotational cycle of the light-driven, chemical motor molecule hemithioindigo.

Read More: Motor Neurons News and Motor Neurons Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to